This Israel-based drug company combines groundbreaking innovation with large-cap stability, as it pursues new and lucrative avenues of cancer treatment. Read More
Analyst Articles
Helicopter ambulances represent a big and growing business. Here’s the best investment play on these airborne medical miracles. Read More
This under-the-radar, South American company is a rising energy powerhouse. Read More
Are “fiscal cliff” worries pushing you over the edge? As we stand on the cusp of 2013, investors should get a grip. There’s plenty of good news to hang onto. Read More
China now strives to become a world-beating aviation manufacturer, to further its rise as a top power. Here’s the best play on the Middle Kingdom’s sky-high ambitions. Read More
As corporate security breaches rise in frequency and severity, this company serves as the “911” for data managers worldwide. Read More
This company enjoys a lock on proprietary technology for increasingly popular mobile devices, providing investors with both growth and safety amid market uncertainty. Read More
Resurgent commercial demand combined with a politically resilient defense budget will propel this undervalued stock to the front ranks of the aerospace sector. Read More
As the world’s farmers seek to boost crop yields, this potash play is poised to generate “green” for investors. Read More
High-stakes patent litigation is an often-overlooked investment opportunity. For this fast-growing technology company, a pending infringement case is likely to pay off big. Read More